Why it was recalled
Subpotent Drug
Product description
Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 59779-534-01. UPC 050428345535
Lot numbers, UPCs & expiration codes
Lot #: TXWP, TXTP, Exp. date Jul 2020; AXTZ, Exp. date Mar 2021; AXNP, Exp. date Jul 2021; AXBC, Exp. date Oct 2021; ZXWW, Exp. date Dec 2021
Where it was sold
Nationwide within the United States, Guam and Saipan
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0323-2020
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- Oct 1, 2019
- FDA report date
- Nov 20, 2019
- Quantity
- 210,744 units
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Sato Pharmaceutical Inc.
Original FDA data
Every field from FDA enforcement report D-0323-2020, exactly as published.
Show all FDA fields
- City
- Torrance
- State
- CA
- Status
- Terminated
- Country
- United States
- Event ID
- 83964
- Address
- 20695 S Western Ave Ste 240
- Code information
- Lot #: TXWP, TXTP, Exp. date Jul 2020; AXTZ, Exp. date Mar 2021; AXNP, Exp. date Jul 2021; AXBC, Exp. date Oct 2021; ZXWW, Exp. date Dec 2021
- Postal code
- 90501-1834
- Report date
- Nov 20, 2019
- Product type
- Drugs
- Recall number
- D-0323-2020
- Classification
- Class III
- Recalling firm
- Sato Pharmaceutical Inc.
- Product quantity
- 210,744 units
- Termination date
- Aug 18, 2020
- Reason for recall
- Subpotent Drug
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 59779-534-01. UPC 050428345535
- Distribution pattern
- Nationwide within the United States, Guam and Saipan
- Recall initiation date
- Oct 1, 2019
- Initial firm notification
- Letter
- Center classification date
- Nov 13, 2019